Arrowhead Research (NASDAQ: ARWR) reported Q3 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $39.58 thousand versus the consensus estimate of $60 thousand.

For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.

Earnings

Piper Jaffray Cuts Price Target on Arrowhead Research (ARWR) to $8.00 Following 3Q August 10, 2016 8:53 AM Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30August 9, 2016 4:52 PM Form 8-K ARROWHEAD PHARMACEUTICAL For: Aug 09August 9, 2016 4:08 PM Arrowhead Reports Fiscal 2016 Third Quarter ResultsAugust 9, 2016 4:01 PM Arrowhead Research (ARWR) Prices $45M Private Stock Offering at $5.90/ShareAugust 9, 2016 9:06 AM Arrowhead Pharmaceuticals Prices $45 Million Private OfferingAugust 9, 2016 9:03 AM